Companies: 10,493     total market cap: NZ$231.082 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Exelixis
EXEL
#1836
Rank
NZ$18.87 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$70.39
Share price
0.64%
Change (1 day)
5.55%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2024: NZ$1.15 Billion

According to Exelixis's latest financial reports the company's current earnings are NZ$2.28 Billion. In 2024 the company made an earning of NZ$1.15 Billion, an increase over its 2023 earnings that were of NZ$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2024

Annual earnings

Year Earnings Change
2024NZ$1.15 B164.69%
2023NZ$0.43 B9.89%
2022NZ$0.39 B-20.33%
2021NZ$0.49 B124.82%
2020NZ$0.22 B-67.14%
2019NZ$0.67 B-11.94%
2018NZ$0.76 B185.09%
2017NZ$0.26 B-325.82%
2016-NZ$0.12 Billion-58.12%
2015-NZ$0.29 Billion-37.61%
2014-NZ$0.46 Billion9.75%
2013-NZ$0.42 Billion65.96%
2012-NZ$0.25 Billion-291.63%
2011NZ$0.13 B-195.59%
2010-NZ$0.14 Billion-42.17%
2009-NZ$0.24 Billion-18.98%
2008-NZ$0.3 Billion-6.99%
2007-NZ$0.32 Billion46.3%
2006-NZ$0.22 Billion33.25%
2005-NZ$0.17 Billion-30.92%
2004-NZ$0.24 Billion44.29%
2003-NZ$0.17 Billion12.86%
2002-NZ$0.15 Billion22.79%
2001-NZ$0.12 Billion60.14%
2000-NZ$72.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.88 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.08 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.96 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.41 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$39.12 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.61 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.79 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-NZ$55.17 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-NZ$49.21 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com